Clinical Trial Update: Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating consolidation pembrolizumab after chemoradiation in patients with inoperable/unresectable stage III non-small cell lung cancer has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Nasser Hanna, M.D. | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2022-01-06